Novartis shareholders to vote on Alcon deal in April; Genoptix buy on track
This article was originally published in Clinica
Executive Summary
Novartis is nearing completion of its bid to buy eyecare company Alcon outright, after setting a date for its shareholders to vote on the final stage of the multi-billion-dollar deal.